Implementation of Reverse Transcriptase PCR Testing for Severe Acute Respiratory Syndrome Coronavirus 2 under the US Food and Drug Administration Emergency Use Authorization

Clin Chem. 2021 Jan 30;67(2):434-435. doi: 10.1093/clinchem/hvaa278.

Authors

Joel A Lefferts¹, Samantha F Allen¹, Heather B Steinmetz¹, Gregory J Tsongalis¹

Affiliation

¹ Laboratory for Clinical Genomics and Advanced Technology, Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Health System, Lebanon, NH, USA; Geisel School of Medicine at Dartmouth, Hanover, NH, USA.

No abstract available

Publication types

Letter

MeSH terms

COVID-19 / diagnosis*
COVID-19 / virology
COVID-19 Testing / methods*
Humans
Reverse Transcriptase Polymerase Chain Reaction / methods*
SARS-CoV-2 / isolation & purification
United States
United States Food and Drug Administration